Severe hypoglycemic episodes: A persistent threat for children with type 1 diabetes mellitus and their families

Journal of Endocrinological Investigation

Volumn 36, Issue 8, 2013, Pages 617-621

  Maltoni, G ^a   Zucchini, S ^a   Scipione, M ^a   Rollo, A ^a   Balsamo, C ^a   Bertolini, C ^a   Baronio, F ^a   Rondelli, R ^a   Pession, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Children; Diabetes; Families; Hypoglycemia; Insulin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; PIG INSULIN;

ADOLESCENT; ARTICLE; CHILD; CLOSED LOOP DEVICE; COMA; DIABETES CONTROL; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; FAMILY; FEAR; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICAL DEVICE; METABOLIC REGULATION; NIGHT; OBSERVATIONAL STUDY; PARENT; PHARMACODYNAMICS; RETROSPECTIVE STUDY; RISK; SEIZURE; TREATMENT OUTCOME; UNCONSCIOUSNESS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INCIDENCE; INFANT; ITALY; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84883719529     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8896     Document Type: Article

References (24)

1. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med 1991, 90: 450-9.
2. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008, 57: 3169-76.
3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356: 1842-52.
4. Skrivarhaug T, Bangstad H-J, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhoodonset type 1 diabetic patients in Norway. Diabetologia 2006, 49: 298-305.
5. Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment andmanagement of hypoglycemia in children and adolescents with diabetes. Pediatric Diabetes 2009, 10 (Suppl 12): 134-45.
6. Alemzadeh R, Berhe T, Wyatt DT. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 2005, 115: 1320-4.
7. McCrimmon RJ, Sherwin RS. Hypoglycemia in type 1 diabetes. Diabetes 2010, 59: 2333-9.
8. Shalitin S, Phillip M. Hypoglycemia in type 1 diabetes. Diabetes Care 2008, 31 (Suppl 2): 121-4.
9. Tamborlane WV. Severe hypoglycemia in youth with T1DM: going, going . but not yet gone. Pediatric Diabetes 2011, 12: 1-3.
10. Shalitin S, Peter Chase H. Diabetes technology and treatment in the paediatric age group. Int J Clin Pract 2011, 65 (Suppl 170): 76-82.
11. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007, 50: 1140-7.
12. Tupola S, Rajantie J, Maenpaa J. Severe hypoglycaemia in children and adolescents during multiple dose insulin therapy. Diabet Med 1998, 15: 695-9.
13. Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence, 2011.
14. Blasetti A, Di Giulio C, Tocco AM, et al. Variables associated with severe hypoglycaemia in children and adolescents with type 1 diabetes: a population-based study. Pediatric Diabetes 2011, 12: 4-10.
15. O'Connell SM, Cooper MN, Bulsara MK, Davis EA, Jones TW. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009. Diabetes Care 2011, 34: 2379-80.
16. Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002, 287: 2511-8.
17. Bulsara MK, Davis EA, Holman DJ, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004, 27: 2293-8.
18. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial. J Pediatr 1994, 125: 177-88.
19. Little S, Shaw J, Home P. Hypoglycemia rates with basal insulin analogs. Diabetes Technol Ther 2011, 13 (Suppl 1): S53-64.
20. Ashwell SG, Amiel SA, Bilous RW, et al. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes. Diabetic Med 2006, 23: 285-92.
21. Craig ME, Handelsman P, Donaghue KC, et al. Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT. Med J Aust 2002, 177: 235-8.
22. Brunelle BL, Llewelyn J, Anderson JH jr, Gale EA, Koivisto VA. Meta-analysis of the effect of insulin lispro on severe hypoglycaemia in patients with type 1 diabetes. Diabetes Care 1998, 21: 1726-31.
23. Cox DJ, Gonder-Frederick L, Ritterband L, Clarke W, Kovatchev BP. Prediction of severe hypoglycemia. Diabetes Care 2007, 30: 1370-3.
24. White NH, Chase P, Arslanian S, Tamborlane WV, for the 4030 Study Group. Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care 2009, 32: 387-93.